WHO Report on Surveillance of Antibiotic Consumption: 2016 - 2018 Early Implementation. WHO. (2018)

immage

This report presents 2015 data on the consumption of systemic antibiotics from 65 countries and areas, contributing to our understanding of how antibiotics are used in these countries. In addition, the report documents early efforts of the World Health Organization (WHO) and participating countries to monitor antimicrobial consumption, describes the WHO global methodology for data collection, and highlights the challenges and future steps in monitoring antimicrobial consumption.


Keywords: AMR, data, surveillance, medicines, tuberculosis

 

Download Publication

Sex Workers’ Experiences of Stock-outs of HIV/STI Commodities and Treatments. NSWP Global Network of Sex Work Projects and ITPC International Treatment Preparedness Coalition. (2018)

immage

Sex workers experienced stock-outs of antiretroviral drugs for HIV in more than half of the countries that responded to the consultation, in all types of health care settings. Sex workers experience forced treatment interruptions and involuntary medication changes due to stock-outs, and are forced to travel long distances to access commodities and treatments due to stock-outs in their local areas. This ultimately leads to a lack of trust in health services and systems.


Keywords: HIV, sex workers, drugs, health care, treatment

 


Download Community Guide and Briefing Paper

Transitioning to an Optimal Paediatric ARV Formulary: Implementation Considerations. WHO. (2018)

immage

Antiretroviral treatment (ART) optimization is a key pillar in the AIDS Free agenda to reach the goal of ensuring 95% of all infants and children have access to lifesaving treatment.

This policy brief outlines key considerations to facilitate effective transition to more clinically appropriate regimens as optimal ARV medicines and dosage forms become available.

 

Keywords: HIV, ARV, paediatric, treatment, children

 

Download Publication
 

AIDS Free Framework to Accelerate Paediatric and Adolescent HIV Treatment. WHO. (2018)

immage

Every child and adolescent living with HIV should have access to antiretroviral therapy (ART). The AIDS Free component of the framework has the specific goal of ensuring 95% of all children and adolescents living with HIV have access to lifelong ART by the end of 2018. These efforts will need to be sustained until 2020, when it is estimated that treating 95% of all children and adolescents living with HIV will require providing ART to 1.4 million children (aged 0-14). and 1 million adolescents (aged 15-19).


Keywords: HIV, ART, children, adolescents, treatment

 

 

Download Publication

What You Need to Know about HIV Testing. UNAIDS. (2018)

immage

Strong global commitment to end AIDS has driven huge progress. In 2017, around 75% of people living with HIV globally knew their HIV status and 59% of all people living with HIV were accessing treatment.

However, new HIV infections are not declining fast enough and too many people are still dying from AIDS-related illnesses despite the availability of high-quality and effective treatment. And with 36.9 million men, women and children living with HIV around the world, there are more people than ever before living with HIV. A quarter don’t even know that they have the virus.


Keywords: HIV, testing, stigma, discrimination, treatment, care

 

Download Publication

When the Drugs Don’t Work: Antibiotic Resistance as a Global Development Problem. Heijden Mvd, Sandgren A, Pränting M, Karvanen M, et al. (2018)

immage

There is a belief that innovation of new antibiotics will out-pace the development and spread of resistant bacteria. However, without rapidly addressing the way antibiotics are currently over- and mis-used, there is no chance of winning this race. Novel antibiotics will continue to play an important role, but they will not be enough. Antibiotics must be seen as a non-renewable resource. And just like in climate change, if this natural resource is exhausted, there will be nothing left for future generations. Managing antibiotic resistance relies on limiting use of antibiotics, discovery of new antibiotics or alternative ways to treat infectious diseases, but also on preventing infections and limiting spread of resistance. There are no quick fixes – antibiotic resistance is a systems failure and thus all sectors need to contribute to a change and jointly securing that antibiotics remain effective.

 

This report focuses on the Sustainable Development Goals related to poverty, economic growth, inequality, health, food production and the environment.   

 


Keywords: HIV/AIDS, TB, SDGs, antibiotic resistance, public health, drugs

 

Download Publication

HIV Self-testing: Quick and Simple. UNAIDS. (2018)

immage

The decision to take an HIV self-test is yours and yours alone. No one else should force you to take an HIV test, either an HIV self-test or any other type of HIV test.

 


Keywords: HIV, self-testing, privacy

 

 

Download Infographics

Progress Report on Access to Hepatitis C Treatment. WHO. (2018)

immage

This report updates the first edition, published in 2016, and reviews the progress countries have made in expanding access to life-saving DAAs. The report reviews the main challenges countries face and describes recent developments in relation to five key factors that determine access to DAA medicines: affordability, quality assurance, regulatory approval, government commitment and financing. It highlights key areas for action by ministries of health and other government decision-makers, pharmaceutical manufacturers and technical partners. 


Keywords: HCV, treatment, medicines, response

 

Download Publication

Ending an Epidemic: Prioritizing People who Inject Drugs in HCV Elimination Efforts. International AIDS Society (IAS). (2018)

immage

Nearly a quarter of the world’s new HCV infections occur among people who inject drugs (PWID): lack of access to sterile needles, syringes and other injection equipment renders them highly vulnerable to HCV. Legal and structural barriers also greatly increase HCV risk among PWID. Worldwide, more than 50% of the 15.6 million PWID are HCV antibody positive. Without urgent, strategic and measurable action that includes PWID, HCV will continue to inflict a staggering, and increasing, burden of preventable illness and death among families, communities and countries. 


Keywords: PWID, HCV, HIV,  treatment, harm reduction

 

Download Publication

An Informal Consultation on Validation of Elimination of Mother-to-Child Transmission of HIV, Hepatitis B and Syphilis. WHO Office of the Representative to Malaysia, Brunei Darussalam and Singapore. (2018)

immage

The consultation was convened in Malaysia (Putrajaya, 27 to 28 February 2018) by the Malaysian Ministry of Health and WHO to discuss potential approaches for validation of mother-to-child transmission of hepatitis B inviting national and international experts.

 

 


Keywords: HIV infections, child, maternal health, hepatitis B, syphilis

 

 

Download Publication

Pages

Data Dashboard
database
Highlighted publications
https://aidsdatahub.org/sites/default/files/highlight-reference/document/ESCAP_Asia_and_the_Pacific_SDG_Progress_Report_2020.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_Progress_Report_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_National_and_Subnational_HIV_Estimates_and_Projections_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_NASA_Report_2016-2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_TB_Global_Report_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-Global-AIDS-Update_Asia-Pacific_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-changing-laws-that-discriminate_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/PNG_HIV_National_Strategic_Information_2018-22.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/PNG_National_STI_and_HIV_Strategy.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-young-peoples-participation-in-community-based-responses-to-hiv_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNODC_factsheet_Ending_AIDS_by_2030_for_people_and_with_PUD_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/HRI-women-harm-reduction-2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Elective_C-section_should_not_be_routinely_recommended_to_WLHIV_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guideline_on_digital_interventions_for_health_system_strengthening_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Progress_report_on_HIV_viral_hepatitis_and_STI_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_HIV_UHC_Guide_Civil_Society_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NSACP_Sri_Lanka_Annual_Report_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_HIV-related-travel-restrictions-explainer_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/HIV-and-the-Law-supplement-2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_IBBS_and_Population_size_estimates_among_FSW_2015.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal_National_Community_Led_HIV_Testing_Guidelines_2018.pdf
Calendar of events
Mar
1
(1 Mar - 1 Mar)
Mar
3
Mar
8
(8 Mar - 8 Mar)